Christopher McGinley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Christopher McGinley has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Byron D. Ford
Department of Anatomy Howard University College of Medicine Washington DC USA
3 shared publications - Gregory D. Ford
Department of Anatomy, Howard University College of Medicine
3 shared publications - Oluwafayokemi Oyolola
Department of Anatomy, Howard University College of Medicine, Washington, DC 20059, USA
3 shared publications - Monique C. Surles-Zeigler
Department of Anatomy, Howard University College of Medicine, Washington, DC 20059, USA
2 shared publications - Oyinkansola Adeyemi
Department of Anatomy, Howard University College of Medicine, Washington, DC 20059, USA
2 shared publications Adib Abla
Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, Florida
1 shared publication
Latest Publications
- Open Access
- 28 September 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12 (13)
Co-occurring scalp arteriovenous malformation and dural arteriovenous fistula with diploic vein involvement: illustrative case
BACKGROUND: Scalp arteriovenous malformations (AVMs) with co-occurring dural arteriovenous fistulas (dAVFs) are a rare combination of vascular pathologies. The additional presence of diploic veins has not yet been documented in the literature. The authors present the first such case and its clinical management accompanied by a review of reported concomitant scalp AVMs and dAVFs in the literature. OBSERVATIONS: A young woman presenting with a large scalp deformity, diplopia, visual decline, and recurrent epistaxis was found to have a co-occurring scalp AVM and dAVF with diploic vein involvement. Combined endovascular therapy and open resection permitted safe removal of the scalp AVM and obliteration of the dAVF. The patient was discharged on postoperative day 6 without complication. LESSONS: A combined approach of endovascular therapy for local control, supplemented by surgical ligation and resection, can yield excellent outcomes in these instances. https://thejns.org/doi/10.3171/CASE26533
- 28 September 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12 (13)
Open AccessCo-occurring scalp arteriovenous malformation and dural arteriovenous fistula with diploic vein involvement: illustrative case
BACKGROUND: Scalp arteriovenous malformations (AVMs) with co-occurring dural arteriovenous fistulas (dAVFs) are a rare combination of vascular pathologies. The additional presence of diploic veins has not yet been documented in the literature. The authors present the first such case and its clinical management accompanied by a review of reported concomitant scalp AVMs and dAVFs in the literature. OBSERVATIONS: A young woman presenting with a large scalp deformity, diplopia, visual decline, and recurrent epistaxis was found to have a co-occurring scalp AVM and dAVF with diploic vein involvement. Combined endovascular therapy and open resection permitted safe removal of the scalp AVM and obliteration of the dAVF. The patient was discharged on postoperative day 6 without complication. LESSONS: A combined approach of endovascular therapy for local control, supplemented by surgical ligation and resection, can yield excellent outcomes in these instances. https://thejns.org/doi/10.3171/CASE26533
- Open Access
Neuregulin-1 as a Context-Dependent Regulator of Neuroinflammation and Neural Repair: Mechanisms, Disease Relevance, and Therapeutic Challenges
Neuroinflammation is a coordinated response to central nervous system injury and disease involving resident glia, neurons, the neurovascular unit, and infiltrating immune cells. Although transient inflammatory signaling supports host defense, debris clearance, and repair, persistent activation contributes to synaptic dysfunction, demyelination, blood–brain barrier disruption, and neuronal loss. Neuregulin-1 (NRG1), a pleiotropic epidermal growth factor family ligand, has emerged as a potential regulator of this balance. Through ErbB receptor complexes, particularly ErbB4-containing dimers, NRG1 influences neural development, myelination, synaptic function, cell survival, and inflammatory signaling. Experimental evidence indicates that NRG1 can restrain NF-κB-dependent transcription, alter microglial activation states, enhance alpha7 nicotinic acetylcholine receptor-associated anti-inflammatory signaling, support oligodendroglial lineage cells, and stabilize neurovascular integrity. However, these actions are context-dependent; in spinal nociceptive circuits, ErbB2-linked signaling can promote microglial activation and pain hypersensitivity. This review examines NRG1 isoform biology, ErbB receptor architecture, cellular targets, and disease-specific evidence across demyelinating disease, stroke, traumatic brain injury, neurodegeneration, cerebral malaria, sickle cell disease, and neuropathic pain. Translation will require isoform-specific, receptor-biased, and anatomically targeted approaches supported by rigorous in vivo validation and verified biomarkers.
Open AccessNeuregulin-1 as a Context-Dependent Regulator of Neuroinflammation and Neural Repair: Mechanisms, Disease Relevance, and Therapeutic Challenges
Neuroinflammation is a coordinated response to central nervous system injury and disease involving resident glia, neurons, the neurovascular unit, and infiltrating immune cells. Although transient inflammatory signaling supports host defense, debris clearance, and repair, persistent activation contributes to synaptic dysfunction, demyelination, blood–brain barrier disruption, and neuronal loss. Neuregulin-1 (NRG1), a pleiotropic epidermal growth factor family ligand, has emerged as a potential regulator of this balance. Through ErbB receptor complexes, particularly ErbB4-containing dimers, NRG1 influences neural development, myelination, synaptic function, cell survival, and inflammatory signaling. Experimental evidence indicates that NRG1 can restrain NF-κB-dependent transcription, alter microglial activation states, enhance alpha7 nicotinic acetylcholine receptor-associated anti-inflammatory signaling, support oligodendroglial lineage cells, and stabilize neurovascular integrity. However, these actions are context-dependent; in spinal nociceptive circuits, ErbB2-linked signaling can promote microglial activation and pain hypersensitivity. This review examines NRG1 isoform biology, ErbB receptor architecture, cellular targets, and disease-specific evidence across demyelinating disease, stroke, traumatic brain injury, neurodegeneration, cerebral malaria, sickle cell disease, and neuropathic pain. Translation will require isoform-specific, receptor-biased, and anatomically targeted approaches supported by rigorous in vivo validation and verified biomarkers.
- Open Access
- 14 August 2026
- Published by MDPI AG in Preprints.org
Neuregulin-1 as a Context-Dependent Regulator of Neuroinflammation and Neural Repair: Mechanisms, Disease Relevance, and Therapeutic Challenges
Neuroinflammation is a coordinated response to central nervous system injury and disease involving resident glia, neurons, the neurovascular unit, and infiltrating immune cells. Although transient inflammatory signaling supports host defense, debris clearance, and repair, persistent activation contributes to synaptic dysfunction, demyelination, blood-brain barrier disruption, and neuronal loss. Neuregulin-1 (NRG1), a pleiotropic epidermal growth factor family ligand, has emerged as a potential regulator of this balance. Through ErbB receptor complexes, particularly ErbB4-containing dimers, NRG1 influences neural development, myelination, synaptic function, cell survival, and inflammatory signaling. Experimental evidence indicates that NRG1 can restrain NF-κB -dependent transcription, alter microglial activation states, enhance alpha7 nicotinic acetylcholine receptor-associated anti-inflammatory signaling, support oligodendroglial lineage cells, and stabilize neurovascular integrity. However, these actions are context dependent; in spinal nociceptive circuits, ErbB2-linked signaling can promote microglial activation and pain hypersensitivity. This review examines NRG1 isoform biology, ErbB receptor architecture, cellular targets, and disease-specific evidence across demyelinating disease, stroke, traumatic brain injury, neurodegeneration, cerebral malaria, sickle cell disease, and neuropathic pain. Translation will require isoform-specific, receptor-biased, and anatomically targeted approaches supported by rigorous in vivo validation and verified biomarkers.
- 14 August 2026
- Published by MDPI AG in Preprints.org
Open AccessNeuregulin-1 as a Context-Dependent Regulator of Neuroinflammation and Neural Repair: Mechanisms, Disease Relevance, and Therapeutic Challenges
Neuroinflammation is a coordinated response to central nervous system injury and disease involving resident glia, neurons, the neurovascular unit, and infiltrating immune cells. Although transient inflammatory signaling supports host defense, debris clearance, and repair, persistent activation contributes to synaptic dysfunction, demyelination, blood-brain barrier disruption, and neuronal loss. Neuregulin-1 (NRG1), a pleiotropic epidermal growth factor family ligand, has emerged as a potential regulator of this balance. Through ErbB receptor complexes, particularly ErbB4-containing dimers, NRG1 influences neural development, myelination, synaptic function, cell survival, and inflammatory signaling. Experimental evidence indicates that NRG1 can restrain NF-κB -dependent transcription, alter microglial activation states, enhance alpha7 nicotinic acetylcholine receptor-associated anti-inflammatory signaling, support oligodendroglial lineage cells, and stabilize neurovascular integrity. However, these actions are context dependent; in spinal nociceptive circuits, ErbB2-linked signaling can promote microglial activation and pain hypersensitivity. This review examines NRG1 isoform biology, ErbB receptor architecture, cellular targets, and disease-specific evidence across demyelinating disease, stroke, traumatic brain injury, neurodegeneration, cerebral malaria, sickle cell disease, and neuropathic pain. Translation will require isoform-specific, receptor-biased, and anatomically targeted approaches supported by rigorous in vivo validation and verified biomarkers.
- Open Access
- 17 July 2026
- Published by Elsevier in Brain and Spine
- Vol. 6
Adult tethered cord syndrome associated with spina bifida occulta and a lipomatous filum terminale: case report and structured literature review
- 17 July 2026
- Published by Elsevier in Brain and Spine
- Vol. 6
Open AccessAdult tethered cord syndrome associated with spina bifida occulta and a lipomatous filum terminale: case report and structured literature review
- 19 February 2026
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 264, 109352
Barriers to expeditious post-operative chemotherapy for patients with glioblastoma
- 19 February 2026
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 264, 109352
Barriers to expeditious post-operative chemotherapy for patients with glioblastoma
- Open Access
- 16 January 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (1) , 117
Redox State of Glutathione and Cysteine in Plasma Following Acute Stroke
Ischemic stroke is a major cause of long-term disability and death, with oxidative stress contributing substantially to post-ischemic injury. Reperfusion restores oxygen supply but simultaneously increases reactive oxygen species (ROS), amplifying secondary neuronal damage. This study examined time-dependent changes in systemic thiol redox status following transient middle cerebral artery occlusion (tMCAO) in rats. Plasma concentrations of cysteine (CySH), cystine (CySS), glutathione (GSH), and glutathione disulfide (GSSG), along with corresponding CySS/CySH and GSSG/GSH ratios and redox potentials (Eh), were evaluated 24 and 48 h after occlusion. At 24 h, thiol concentrations and redox ratios showed no significant differences between sham and tMCAO groups. By 48 h, a marked oxidative shift emerged, characterized by reduced CySH, elevated GSSG, and significant increases in both CySS/CySH and GSSG/GSH ratios. Redox potentials also demonstrated substantial oxidation at this time point. These findings indicate that prolonged ischemia–reperfusion induces systemic oxidative stress, with plasma redox status serving as a sensitive indicator of reperfusion-related injury. The results underscore the plasma redox status as a potentially sensitive biomarker of reperfusion-induced oxidative injury and support the therapeutic value of targeting redox imbalance to mitigate oxidative damage following stroke.
- 16 January 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (1) , 117
Open AccessRedox State of Glutathione and Cysteine in Plasma Following Acute Stroke
Ischemic stroke is a major cause of long-term disability and death, with oxidative stress contributing substantially to post-ischemic injury. Reperfusion restores oxygen supply but simultaneously increases reactive oxygen species (ROS), amplifying secondary neuronal damage. This study examined time-dependent changes in systemic thiol redox status following transient middle cerebral artery occlusion (tMCAO) in rats. Plasma concentrations of cysteine (CySH), cystine (CySS), glutathione (GSH), and glutathione disulfide (GSSG), along with corresponding CySS/CySH and GSSG/GSH ratios and redox potentials (Eh), were evaluated 24 and 48 h after occlusion. At 24 h, thiol concentrations and redox ratios showed no significant differences between sham and tMCAO groups. By 48 h, a marked oxidative shift emerged, characterized by reduced CySH, elevated GSSG, and significant increases in both CySS/CySH and GSSG/GSH ratios. Redox potentials also demonstrated substantial oxidation at this time point. These findings indicate that prolonged ischemia–reperfusion induces systemic oxidative stress, with plasma redox status serving as a sensitive indicator of reperfusion-related injury. The results underscore the plasma redox status as a potentially sensitive biomarker of reperfusion-induced oxidative injury and support the therapeutic value of targeting redox imbalance to mitigate oxidative damage following stroke.
- Open Access
- 16 September 2025
- Published by Edorium Journals Pvt. Ltd. in Journal of Case Reports and Images in Surgery
- Vol. 12 (2) , 14-18
The use of polymethyl methacrylate as an effective tamponade for a vertebral artery injury during anterior cervical corpectomy and fusion: A case report
Introduction: Injury to the vertebral artery (VA) during an anterior cervical approach to the spine is relatively uncommon. These injuries can be difficult to repair, may lead to significant complications, and can even be fatal. We present a case report involving a VA injury that occurred during an anterior cervical corpectomy and fusion and discuss its management. Case Report: A 65-year-old man presented with a chief complaint of radicular left upper extremity pain without weakness, numbness, or paresthesia. Imaging revealed cervical spondylosis with a kyphotic deformity. An anterior cervical corpectomy and fusion was recommended and the patient agreed to proceed with the surgery. During the drilling of the vertebral body, the left lateral wall of the vertebral body was inadvertently perforated, resulting in an injury to the VA. To address this complication polymethyl methacrylate (PMMA) was placed in the defect to replace the vertebral body and provide effective tamponade against the bleed. Conclusion: Polymethylmethacrylate can be a very effective tool to use in the management of an injury to the VA, providing the ability to tamponade while simultaneously helping to maintain structural integrity and spinal stability.
- 16 September 2025
- Published by Edorium Journals Pvt. Ltd. in Journal of Case Reports and Images in Surgery
- Vol. 12 (2) , 14-18
Open AccessThe use of polymethyl methacrylate as an effective tamponade for a vertebral artery injury during anterior cervical corpectomy and fusion: A case report
Introduction: Injury to the vertebral artery (VA) during an anterior cervical approach to the spine is relatively uncommon. These injuries can be difficult to repair, may lead to significant complications, and can even be fatal. We present a case report involving a VA injury that occurred during an anterior cervical corpectomy and fusion and discuss its management. Case Report: A 65-year-old man presented with a chief complaint of radicular left upper extremity pain without weakness, numbness, or paresthesia. Imaging revealed cervical spondylosis with a kyphotic deformity. An anterior cervical corpectomy and fusion was recommended and the patient agreed to proceed with the surgery. During the drilling of the vertebral body, the left lateral wall of the vertebral body was inadvertently perforated, resulting in an injury to the VA. To address this complication polymethyl methacrylate (PMMA) was placed in the defect to replace the vertebral body and provide effective tamponade against the bleed. Conclusion: Polymethylmethacrylate can be a very effective tool to use in the management of an injury to the VA, providing the ability to tamponade while simultaneously helping to maintain structural integrity and spinal stability.